Economic Impact Linked To the Reduction of Exacerbations When A Treatment Regime With Inhaled Antibiotics Is Switched To Aztreonam Lysine In Patients With Cystic Fibrosis and Chronic Pulmonary Infection Caused By Pseudomonas Aeruginosa

Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.1659
https://www.valueinhealthjournal.com/article/S1098-3015(14)03589-X/fulltext
Title : Economic Impact Linked To the Reduction of Exacerbations When A Treatment Regime With Inhaled Antibiotics Is Switched To Aztreonam Lysine In Patients With Cystic Fibrosis and Chronic Pulmonary Infection Caused By Pseudomonas Aeruginosa
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)03589-X&doi=10.1016/j.jval.2014.08.1659
First page : A526
Section Title : Disease-Specific Studies
Open access? : No
Section Order : 1136
Categories :
Tags :
Regions :
ViH Article Tags :